BC Extra | Nov 5, 2019
Financial News

Following JV, Sino backs Akeso's $150M series D

Six months after establishing a joint venture with Akeso, Sino Biopharmaceutical has co-led a series D round of about $150 million in the Zhongshan-based cancer and autoimmune company. Loyal Valley Capital co-led the round, which...
Items per page:
1 - 1 of 1